Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

Nature Genetics

Volumn 29, Issue 4, 2001, Pages 418-425

  Jonkers, Jos ^a   Meuwissen, Ralph ^a   Van der Gulden, Hanneke ^a   Peterse, Hans ^a   Van der Valk, Martin ^a   Berns, Anton ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; PROTEIN P53;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER MODEL; CANCER RISK; FEMALE; GENE INACTIVATION; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; BRCA2 PROTEIN; DISEASE MODELS, ANIMAL; GENES, P53; GENES, TUMOR SUPPRESSOR; LOSS OF HETEROZYGOSITY; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC;

ANIMALIA; MUS MUSCULUS;

EID: 0035734285     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng747     Document Type: Article

References (50)

1. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
2. In search of the tumour-suppressor functions of BRCA1 and BRCA2
3. The breast cancer susceptibility gene, BRCA2: At the crossroads between DNA replication and recombination?
4. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation
5. Involvement of Brca2 in DNA repair
6. BRCA2 is required for homology-directed repair of chromosomal breaks
7. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
8. A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression
9. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment
10. The BRCA2 gene product functionally interacts with p53 and RAD51
11. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene Brca2
12. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
13. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein
14. Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p 53 nullizygous embryos
15. Brca2 is required for embryonic cellular proliferation in the mouse
16. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
17. Thymic lymphomas in mice with a truncating mutation in Brca2
18. p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
19. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
20. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2
21. The magical touch: Genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin
22. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice
23. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites
24. Inducible gene targeting in mice using the Cre/lox system
25. Conditional gene targeting
26. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells
27. Double indemnity: p53, BRCA and cancer, p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair
28. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
29. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice
30. Genetic background alters the spectrum of tumors that develop in p53-deficient mice
31. Tumor spectrum analysis in p53-mutant mice
32. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p 53 gene
33. Cre-mediated gene deletion in the mammary gland
34. Generalized lacZ expression with the ROSA26 Cre reporter strain
35. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
36. Cancer-susceptibility genes. Gatekeepers and caretakers
37. Molecular portraits of human breast tumours
38. Cancer risks in BRCA2 mutation carriers
39. Xeroderma pigmentosum and related disorders: Defects in DNA repair and transcription
40. Reduced ligation during DNA base excision repair supported by BRCA2 mutant cells
41. Estrogens as endogenous genotoxic agents - DNA adducts and mutations
42. Is estradiol a genotoxic mutagenic carcinogen?
43. p107 is a suppressor of retinoblastoma development in pRb-deficient mice
44. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells
45. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair
46. The integration sites of endogenous and exogenous Moloney murine leukemia virus
47. Simplified mammalian DNA isolation procedure
48. Preparing mammary gland whole mounts from mice